Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...

To support physicians in treating cancer patients, oncology laboratories can benefit from adopting end-to-end automation of flow cytometry workflows. Rapid advances in automation are improving ...

Mar. 13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States ...

Immunizing mice with an edited Lyme disease-causing bacterial protein effectively protected them against the disease.

Immunotherapy Research: Independently design, plan, and execute experiments involving CAR-T cell engineering, optimization, and evaluation using advanced cellular, molecular, and immunological ...

The Postdoctoral Scholar will lead innovative research projects focused on the development and evaluation of immunotherapies for brain tumors, with an emphasis on CAR-T cell therapy. This position ...

CD47-amyloid-β-CD74 signaling is a key driver of adaptive immunosuppression in sepsis, suppressing B cells and impairing ...

西安交通大学第一附属医院的研究人员挺身而出，勇挑攻克胰腺癌治疗难题的重担。他们开展了一项意义重大的研究，聚焦于叶绿素铜钠盐联合吉西他滨治疗胰腺癌的效果及机制探究。研究发现，叶绿素铜钠盐与吉西他滨联合使用，能显著发挥协同抗肿瘤作用，有效抑制胰腺癌细胞的增殖、侵袭和迁移，诱导细胞凋亡，在体内实验中也成功抑制了肿瘤生长，且安全性良好。这一成果为胰腺癌患者带来了新的希望，为胰腺癌的治疗开辟了一条新的道路。